The double-edged sword of dietary fiber: tailoring fiber intake for gut health in autoimmune conditions

Heather Armstrong, from University of Manitoba and University of Alberta (Canada), explores the intricate role of dietary fibers in maintaining gut health, focusing on the microbiome’s ability to process these…

Tumor microbiome, immunity, and prognosis: a comprehensive atlas

This article presents “The Cancer Microbiota Database," an interactive and customizable tool to investigate 33 types of cancers.

Specific gut metabolites may help diagnose endometriosis

The findings suggest that 4-hydroxyindole could be a promising biomarker for diagnosing endometriosis.

Personalized nutrition in a changing world: addressing global health challenges with lifestyle medicine and omics

Hellas Cena, from University of Pavia (Italy), emphasizes the growing importance of nutrition in addressing current global health challenges.

MaaT Pharma reports positive Phase 1b results for MaaT033 in ALS, setting the stage for future advances

A significant milestone for both microbiome research and neurodegenerative diseases.

Core gut microbiota signature may serve as health indicator

The study identified a core microbiota signature that may serve as a health indicator and a therapeutic target.

Understanding the gut microbiota in athletes

Standardizing microbiome analysis improves the quality and reliability of data, helping researchers to explore the gut microbiota’s impact on athletes and its relationship with health and performance.

Microbial signatures for food traceability: ensuring quality and safety from fermented wines to novel insect-based foods

The interview with Antonia Bruno, from Bicocca University of Milan (Italy), highlights research focused on using microbial signatures to enhance food traceability, ensuring both safety and quality. 

Freya Biosciences secures $10.4 million investment to tackle women’s health challenges

A Bill & Melinda Gates Foundation strategic investment to tackle bacterial vaginosis and improve maternal and neonatal health outcomes worldwide.

From Biofarma Group a probiotic therapy as an adjuvant to cancer immunotherapy

Biofarma Group has launched an innovative project in collaboration with the Department of Surgery, Endocrinology and Gastroenterology of the University of Naples ‘Federico II’, the Centro Sperimentale del Latte (CSL)…

Subscribe to MicrobiomePost newsletter

Take full advantage of MicrobiomePost‘s features.

Scroll to Top